These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39415926)

  • 21. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
    Salaverria I; Philipp C; Oschlies I; Kohler CW; Kreuz M; Szczepanowski M; Burkhardt B; Trautmann H; Gesk S; Andrusiewicz M; Berger H; Fey M; Harder L; Hasenclever D; Hummel M; Loeffler M; Mahn F; Martin-Guerrero I; Pellissery S; Pott C; Pfreundschuh M; Reiter A; Richter J; Rosolowski M; Schwaenen C; Stein H; Trümper L; Wessendorf S; Spang R; Küppers R; Klapper W; Siebert R; ; ;
    Blood; 2011 Jul; 118(1):139-47. PubMed ID: 21487109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review].
    Yu Y; Sun Q; Li CW; Jia YJ; Liu W; Wang TY; Lyu R; Yan YT; An G; Qiu LG; Zou DH; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):475-480. PubMed ID: 35968590
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement.
    Zhang Y; Li A; Li Y; Ouyang B; Wang X; Zhang L; Xu H; Gu Y; Lu X; Dong L; Yi H; Wang C
    Am J Surg Pathol; 2024 Nov; 48(11):1341-1348. PubMed ID: 39172106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity.
    Bhavsar S; Liu YC; Gibson SE; Moore EM; Swerdlow SH
    Am J Surg Pathol; 2022 Jan; 46(1):71-82. PubMed ID: 34392269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT; Cheng AL; Hou HA
    Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
    Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N
    Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation.
    Trecourt A; Mauduit C; Szablewski V; Fontaine J; Balme B; Donzel M; Laurent C; Sesques P; Ghesquières H; Bachy E; Salles G; Emile JF; Chassagne-Clément C; Genestier L; Copie-Bergman C; Traverse-Glehen A
    Am J Surg Pathol; 2022 Jan; 46(1):58-70. PubMed ID: 34265801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution.
    Lim S; Koh J; Bae JM; Yun H; Lee C; Paik JH; Kim TM; Jeon YK
    Diagn Pathol; 2024 Jun; 19(1):86. PubMed ID: 38909266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
    Verma A; Epari S; Gujral S; Shet T
    Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.
    Gibson SE; Liu YC; Yatsenko SA; Barasch NJ; Swerdlow SH
    Mod Pathol; 2022 Jan; 35(1):60-68. PubMed ID: 34601504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large B-cell lymphoma with IRF4 rearrangement-Fine needle biopsy-Report of a case with an atypical presentation.
    Barroca H; Marques C; Soares MJ
    Diagn Cytopathol; 2023 Nov; 51(11):E322-E327. PubMed ID: 37571800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of MUM-1/IRF4 protein expression in follicular lymphoma].
    Huo YY; Pan Y; Guan BX; Fang AJ; Sun BC; Zhou GY; Fu K; Meng B
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):528-31. PubMed ID: 22169641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
    Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
    Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare mature B-cell lymphomas in children and adolescents.
    Woessmann W; Quintanilla-Martinez L
    Hematol Oncol; 2019 Jun; 37 Suppl 1():53-61. PubMed ID: 31187530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
    Feldman AL; Law M; Remstein ED; Macon WR; Erickson LA; Grogg KL; Kurtin PJ; Dogan A
    Leukemia; 2009 Mar; 23(3):574-80. PubMed ID: 18987657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
    Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.